Follow
JOE VILJOEN
JOE VILJOEN
PhD Pharmaceutics, NWU, Potchefstroom campus, South Africa
Verified email at nwu.ac.za
Title
Cited by
Cited by
Year
Cutaneous tuberculosis overview and current treatment regimens
L Van Zyl, J Du Plessis, J Viljoen
Tuberculosis 95 (6), 629-638, 2015
2422015
Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets
JM Viljoen, JH Steenekamp, AF Marais, AF Kotzé
Drug development and industrial pharmacy 40 (6), 730-742, 2014
682014
Penetration enhancing effects of selected natural oils utilized in topical dosage forms
JM Viljoen, A Cowley, J Du Preez, M Gerber, J Du Plessis
Drug development and industrial pharmacy 41 (12), 2045-2054, 2015
632015
Essential fatty acids as transdermal penetration enhancers
L Van Zyl, J Du Preez, M Gerber, J Du Plessis, J Viljoen
Journal of Pharmaceutical Sciences 105 (1), 188-193, 2016
392016
Development of a self-emulsifying drug delivery system for optimized topical delivery of clofazimine
D Van Staden, J Du Plessis, J Viljoen
Pharmaceutics 12 (6), 523, 2020
362020
Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their In vitro Efficacy Against Mycobacterium tuberculosis
L Van Zyl, JM Viljoen, RK Haynes, M Aucamp, AH Ngwane, J du Plessis
AAPS PharmSciTech 20, 1-11, 2019
282019
Development of topical/transdermal self-emulsifying drug delivery systems, not as simple as expected
D Van Staden, J Du Plessis, J Viljoen
Scientia pharmaceutica 88 (2), 17, 2020
252020
Impact of traditional African medicine on drug metabolism and transport
C Calitz, JH Steenekamp, JD Steyn, C Gouws, JM Viljoen, JH Hamman
Expert opinion on drug metabolism & toxicology 10 (7), 991-1003, 2014
152014
Anti-melanoma activities of artemisone and prenylated amino-artemisinins in combination with known anticancer drugs
HN Wong, A Lewies, M Haigh, JM Viljoen, JF Wentzel, RK Haynes, ...
Frontiers in Pharmacology 11, 558894, 2020
132020
Herb-drug pharmacokinetic interactions: transport and metabolism of indinavir in the presence of selected herbal products
C Calitz, C Gouws, J Viljoen, J Steenekamp, L Wiesner, E Abay, ...
Molecules 20 (12), 22113-22127, 2015
132015
Novel non-invasive protein and peptide drug delivery approaches
L Wallis, E Kleynhans, TD Toit, C Gouws, D Steyn, J Steenekamp, ...
Protein and Peptide Letters 21 (11), 1087-1101, 2014
112014
Adapting clofazimine for treatment of cutaneous tuberculosis by using self-double-emulsifying drug delivery systems
D van Staden, RK Haynes, JM Viljoen
Antibiotics 11 (6), 806, 2022
102022
Formulation and evaluation of selected transmucosal dosage forms containing a double fixed-dose of acyclovir and ketoconazole
JM Viljoen, D Botes, JH Steenekamp
European Journal of Pharmaceutical Sciences 111, 503-513, 2018
72018
Print parameter optimisation for a Pluronic F-127 and alginate hybrid hydrogel
M Hibbert, JM Viljoen, LH du Plessis
Bioprinting 30, e00257, 2023
62023
Solidification of self-emulsifying drug delivery systems as a novel approach to the management of uncomplicated malaria
EB Seo, LH du Plessis, JM Viljoen
Pharmaceuticals 15 (2), 120, 2022
52022
Development and validation of the simultaneous determination of artemisone, clofazimine and decoquinate with HPLC
JL Du Preez, ME Aucamp, C Burger, M Gerber, JM Viljoen, L Zyl, J Plessis
Die Pharmazie-An International Journal of Pharmaceutical Sciences 73 (3 …, 2018
52018
Investigating in vitro and ex vivo properties of artemether/lumefantrine double-fixed dose combination lipid matrix tablets prepared by hot fusion
CA Wilkins, LH du Plessis, JM Viljoen
Pharmaceutics 13 (7), 922, 2021
42021
Characterization of solid lipid dispersions prepared by hot fusion containing a double-fixed dose combination of artemether and lumefantrine
CA Wilkins, LH Du Plessis, JM Viljoen
Drug Development and Industrial Pharmacy 46 (8), 1289-1297, 2020
42020
Formulation of Medicated Chewing Gum Containing Sceletium tortuosum and Process Optimization Utilizing the SeDeM Diagram Expert System
JM Viljoen, S van der Walt, JH Hamman
AAPS PharmSciTech 22, 1-15, 2021
32021
The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems
D van Staden, RK Haynes, JM Viljoen
Pharmaceutics 15 (4), 1293, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20